A1,
A2,
B,
C1,
C2,
D,
E,
F,
G-H,
I-K,
L,
M,
N,
O,
P1,
P2,
Q-R,
S,
T,
U-V,
W-Z
Uroxatral Indications, Dosage, Storage, Stability - Alfuzosin HCl
Uroxatral Indications, Dosage, Storage, Stability - Alfuzosin HCl
INDICATIONS AND USAGE
UROXATRAL (alfuzosin HCl extended-release tablets) is indicated
for the treatment of the signs and symptoms of benign prostatic hyperplasia.
UROXATRAL is not indicated for the treatment of hypertension.
DOSAGE AND ADMINISTRATION
The recommended dosage is one 10 mg UROXATRAL (alfuzosin HCl
extended-release tablets) tablet daily to be taken immediately after the same
meal each day. The tablets should not be chewed or crushed.
HOW SUPPLIED
UROXATRAL (alfuzosin HCl extended-release tablets) 10 mg is
available as a round, three-layer tablet: one white layer between two yellow
layers, debossed with X10. UROXATRAL is supplied as follows:
|
Package
|
NDC Number
|
|
Bottles of 30
|
0024-4200-30
|
|
Bottles of 100
|
0024-4200-10
|
Hospital Unit Dose (blister packs containing 10 cards of 10
tablets each) 0024-4200-20
Store at 25oC (77oF); excursions permitted
to 15o to 30oC (59o to 86oF) [see
USP Controlled Room Temperature].
Protect from light and moisture.
Keep UROXATRAL out of reach of children.
Distributed by: Sanofi-Synthelabo Inc., New
York, NY 10016 UROXATRAL™ is a trademark of Sanofi-Synthelabo. Code and
date of preparation:
Updated Sep 04, 2003
top
